{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T04:10:31Z","timestamp":1794283831982,"version":"4.9.0"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T00:00:00Z","timestamp":1538006400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02129","type":"journal-article","created":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T01:18:08Z","timestamp":1538011088000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":106,"title":["Interferon-\u03b1 Up-Regulates the Expression of PD-L1 Molecules on Immune Cells Through STAT3 and p38 Signaling"],"prefix":"10.3389","volume":"9","author":[{"given":"Alexandr V.","family":"Bazhin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"von Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Karakhanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,9,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1359-6101(01)00022-3","article-title":"Interferon-alpha in tumor immunity and immunotherapy","volume":"13","author":"Belardelli","year":"2002","journal-title":"Cytokine Growth Factor Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1053\/sonc.2002.33078","article-title":"Cancer immunotherapy: the interferon-alpha experience","volume":"29","author":"Kirkwood","year":"2002","journal-title":"Semin Oncol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1073\/pnas.91.4.1198","article-title":"Cytokine therapeutics: lessons from interferon alpha","volume":"91","author":"Gutterman","year":"1994","journal-title":"Proc Natl Acad Sci USA."},{"key":"B4","first-page":"1919","article-title":"Interferons inhibit EGF-stimulated cell growth and reduce EGF binding in human breast cancer cells","volume":"16","author":"Iacopino","year":"1996","journal-title":"Anticancer Res."},{"key":"B5","first-page":"1499","article-title":"Interferon-alpha restitutes the chemosensitivity in pancreatic cancer","volume":"28","author":"Hoffmann","year":"2008","journal-title":"Anticancer Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/CJI.0b013e318157c682","article-title":"Interferon-alpha in combination with chemotherapy has potent antiangiogenic properties in an orthotopic mouse model for pancreatic adenocarcinoma","volume":"31","author":"Zhu","year":"2008","journal-title":"J Immunother."},{"key":"B7","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/nature07815","article-title":"IFNalpha activates dormant haematopoietic stem cells in vivo","volume":"458","author":"Essers","year":"2009","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.yexcr.2014.03.020","article-title":"Influence of interferon-alpha on the expression of the cancer stem cell markers in pancreatic carcinoma cells","volume":"324","author":"Zhu","year":"2014","journal-title":"Exp Cell Res."},{"key":"B9","first-page":"2489","article-title":"Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons","volume":"58","author":"Pfeffer","year":"1998","journal-title":"Cancer Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e25736","DOI":"10.4161\/onci.25736","article-title":"Overcoming immunosuppression as a new immunotherapeutic approach against pancreatic cancer","volume":"2","author":"Bazhin","year":"2013","journal-title":"Oncoimmunology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00262-013-1485-8","article-title":"Two immune faces of pancreatic adenocarcinoma: possible implication for immunotherapy","volume":"63","author":"Bazhin","year":"2014","journal-title":"Cancer Immunol Immunother."},{"key":"B12","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrc1613","article-title":"Immunotherapy and chemotherapy\u2013a practical partnership","volume":"5","author":"Lake","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/284316a0","article-title":"Synthesis in E. coli of a polypeptide with human leukocyte interferon activity","volume":"284","author":"Nagata","year":"1980","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1146\/annurev.immunol.23.021704.115611","article-title":"The B7 family revisited","volume":"23","author":"Greenwald","year":"2005","journal-title":"Annu Rev Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jdermsci.2005.06.008","article-title":"IFN-gamma regulates the expression of B7-H1 in dermal fibroblast cells","volume":"40","author":"Lee","year":"2005","journal-title":"J Dermatol Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1182\/blood-2006-10-051482","article-title":"Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-{gamma} and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway","volume":"110","author":"Liu","year":"2007","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1080\/07357900801941852","article-title":"TLR4 signaling induces B7-H1 expression through MAPK pathways in bladder cancer cells","volume":"1","author":"Qian","year":"2008","journal-title":"Cancer Invest."},{"key":"B18","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/eji.200939289","article-title":"ERK\/p38 MAP-kinases and PI3K are involved in the differential regulation of B7-H1 expression in DC subsets","volume":"40","author":"Karakhanova","year":"2010","journal-title":"Eur J Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1189\/jlb.1209788","article-title":"IL-27 renders DC immunosuppressive by induction of B7-H1","volume":"89","author":"Karakhanova","year":"2011","journal-title":"J Leukoc Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1600-065X.2010.00923.x","article-title":"The PD-1 pathway in tolerance and autoimmunity","volume":"236","author":"Francisco","year":"2010","journal-title":"Immunol Rev."},{"key":"B21","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1182\/blood-2012-10-385591","article-title":"The role of B7 family molecules in hematologic malignancy","volume":"121","author":"Greaves","year":"2013","journal-title":"Blood"},{"key":"B22","first-page":"179","article-title":"Immunoregulatory role of B7-H1 in chronicity of inflammatory responses","volume":"3","author":"Dong","year":"2006","journal-title":"Cell Mol Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1158\/0008-5472.CAN-05-4303","article-title":"Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up","volume":"66","author":"Thompson","year":"2006","journal-title":"Cancer Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1073\/pnas.0611533104","article-title":"Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer","volume":"104","author":"Hamanishi","year":"2007","journal-title":"Proc Natl Acad Sci USA."},{"key":"B25","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.canlet.2008.03.056","article-title":"Clinical significance and regulation of the costimulatory molecule B7-H1 in pancreatic cancer","volume":"268","author":"Loos","year":"2008","journal-title":"Cancer Lett."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1002\/cncr.24899","article-title":"Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma","volume":"116","author":"Hino","year":"2010","journal-title":"Cancer"},{"key":"B27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1155\/2013\/389807","article-title":"Interferon-\u03b3 triggers hepatic stellate cell-mediated immune regulation through MEK\/ERK signaling pathway","volume":"2013","author":"Gu","year":"2013","journal-title":"Clin Dev Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","article-title":"Engagement of the Pd-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation","volume":"192","author":"Freeman","year":"2000","journal-title":"J Exp Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"6634","DOI":"10.4049\/jimmunol.178.10.6634","article-title":"B7-H1 up-regulation on myeloid dendritic cells significantly suppresses T cell immune function in patients with chronic hepatitis B","volume":"178","author":"Chen","year":"2007","journal-title":"J Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jneuroim.2004.06.013","article-title":"Interferon-\u03b2 enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis","volume":"155","author":"Schreiner","year":"2004","journal-title":"J Neuroimmunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e105636","DOI":"10.1371\/journal.pone.0105636","article-title":"Increased antigen presentation but impaired T cells priming after upregulation of interferon-beta induced by lipopolysaccharides is mediated by upregulation of B7H1 and GITRL","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS ONE"},{"key":"B32","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jhep.2006.05.007","article-title":"PD-L1 is induced in hepatocytes by viral infection and by interferon-alpha and -gamma and mediates T cell apoptosis","volume":"45","author":"Muhlbauer","year":"2006","journal-title":"J Hepatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.imlet.2015.09.017","article-title":"In vitro immunomodulatory properties of gemcitabine alone and in combination with interferon-alpha","volume":"168","author":"Fritz","year":"2015","journal-title":"Immunol Lett."},{"key":"B34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.trim.2015.12.001","article-title":"Interferon-\u03b3, interleukin-10 and interferon-inducible protein 10 (CXCL10) as serum biomarkers for the early allograft dysfunction after liver transplantation","volume":"34","author":"Karakhanova","year":"2016","journal-title":"Transpl Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.clim.2008.07.030","article-title":"B7-H1 on myeloid-derived suppressor cells in immune suppression by a mouse model of ovarian cancer","volume":"129","author":"Liu","year":"2008","journal-title":"Clin Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/TP.0b013e31823ffd39","article-title":"Myeloid-derived suppressor cells (MDSC) protect islet transplants via B7-H1 mediated enhancement of T regulatory cells","volume":"93","author":"Chou","year":"2012","journal-title":"Transplantation"},{"key":"B37","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1471-2407-8-57","article-title":"FOXP3(+)T(regs)and B7-H1(+)\/PD-1(+)T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: implication for immunotherapy","volume":"8","author":"Ghebeh","year":"2008","journal-title":"BMC Cancer"},{"key":"B38","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nm863","article-title":"Blockade of B7-H1 improves myeloid dendritic cell\u2013mediated antitumor immunity","volume":"9","author":"Curiel","year":"2003","journal-title":"Nat Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1002\/eji.201040422","article-title":"Chitin induces upregulation of B7-H1 on macrophages and inhibits T-cell proliferation","volume":"40","author":"Wagner","year":"2010","journal-title":"Eur J Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"5227","DOI":"10.4049\/jimmunol.1103382","article-title":"IL-27 production and STAT3-dependent upregulation of B7-H1 mediate immune regulatory functions of liver plasmacytoid DC","volume":"188","author":"Matta","year":"2012","journal-title":"J Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/hepr.13067","article-title":"A multicenter, randomized, controlled trial of S-1 monotherapy versus S-1 and interferon-\u03b1 combination therapy for hepatocellular carcinoma with extrahepatic metastases","volume":"48","author":"Nagano","year":"2018","journal-title":"Hepatol Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/01.cji.0000211317.15278.27","article-title":"Impact of interferon-\u03b1 in combined chemoradioimmunotherapy for pancreatic adenocarcinoma (CapRI): first data from the immunomonitoring","volume":"30","author":"Schmidt","year":"2007","journal-title":"J Immunother."},{"key":"B43","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1200\/jco.2011.38.2960","article-title":"Open-label, multicenter, randomized phase III trial of adjuvant chemoradiation plus interferon alfa-2b versus fluorouracil and folinic acid for patients with resected pancreatic adenocarcinoma","volume":"30","author":"Schmidt","year":"2012","journal-title":"J Clin Oncol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"4104","DOI":"10.3390\/ijms15034104","article-title":"Influence of interferon-alpha combined with chemo (radio) therapy on immunological parameters in pancreatic adenocarcinoma","volume":"15","author":"Karakhanova","year":"2014","journal-title":"Int J Mol Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1182\/blood.V100.1.230","article-title":"Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6","volume":"100","author":"Ratta","year":"2002","journal-title":"Blood"},{"key":"B46","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/hep.20366","article-title":"Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B","volume":"40","author":"van der Molen","year":"2004","journal-title":"Hepatology"},{"key":"B47","unstructured":"Quantitative and functional defects of dendritic cells in classic Kaposi's sarcoma31729 DellaBella S NicolaS BrambillaL RivaA FerrucciS PresicceP Clin Immunol.1192006"},{"key":"B48","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/cncr.22092","article-title":"Deficiencies in myeloid antigen-presenting cells in women with cervical squamous intraepithelial lesions","volume":"107","author":"Lee","year":"2006","journal-title":"Cancer"},{"key":"B49","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.3748\/wjg.v12.i20.3275","article-title":"Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinoma","volume":"12","author":"Ormandy","year":"2006","journal-title":"World J Gastroenterol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.4049\/jimmunol.178.5.2763","article-title":"Dendritic cells infiltrating human non-small cell lung cancer are blocked at immature stage","volume":"178","author":"Perrot","year":"2007","journal-title":"J Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/sj.bjc.6604018","article-title":"Numerical and functional defects of blood dendritic cells in early- and late-stage breast cancer","volume":"97","author":"Pinzon-Charry","year":"2007","journal-title":"Br J Cancer"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.3892\/ijo_00000301","article-title":"Impact of surgery and chemotherapy on cellular immunity in pancreatic carcinoma patients in view of an integration of standard cancer treatment with immunotherapy","volume":"34","author":"Bellone","year":"2009","journal-title":"Int J Oncol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat Rev Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/ijc.1503","article-title":"Active immunization against cancer with dendritic cells: the near future","volume":"94","author":"Steinman","year":"2001","journal-title":"Int J Cancer"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/nm1147","article-title":"Therapeutic dendritic-cell vaccine for chronic HIV-1 infection","volume":"10","author":"Lu","year":"2004","journal-title":"Nat Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1084\/jem.191.10.1777","article-title":"Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-Pbl-Scid mice","volume":"191","author":"Santini","year":"2000","journal-title":"J Exp Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1189\/jlb.0403154","article-title":"Functional repertoire of dendritic cells generated in granulocyte macrophage-colony stimulating factor and interferon-\u03b1","volume":"75","author":"Della","year":"2004","journal-title":"J Leukoc Biol."},{"key":"B58","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1385\/1-59259-939-7:167","article-title":"Type I interferons as regulators of the differentiation\/activation of human dendritic cells","volume-title":"Interferon Methods and Protocols","author":"Santini","year":"2005"},{"key":"B59","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/978-3-540-71029-5_14","article-title":"IFN-alpha in the generation of dendritic cells for cancer immunotherapy","volume-title":"Dendritic Cells","author":"Santini","year":"2009"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cyto.2014.07.258","article-title":"Interferon alpha induces generation of semi-mature dendritic cells with high pro-inflammatory and cytotoxic potential","volume":"71","author":"Leplina","year":"2015","journal-title":"Cytokine"},{"key":"B61","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/eji.201040979","article-title":"PD-L1 expression on tolerogenic APCs is controlled by STAT-3","volume":"41","author":"W\u00f6lfle","year":"2011","journal-title":"Eur J Immunol."},{"key":"B62","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1073\/pnas.94.2.634","article-title":"Interferon-\u03b1\/\u03b2 inhibition of interleukin 12 and interferon-\u03b3 production in vitro and endogenously during viral infection","volume":"94","author":"Cousens","year":"1997","journal-title":"Proc Natl Acad Sci USA."},{"key":"B63","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.4049\/jimmunol.160.9.4298","article-title":"Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development","volume":"160","author":"McRae","year":"1998","journal-title":"J Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00262-015-1791-4","article-title":"IL-6 down-regulates HLA class II expression and IL-12 production of human dendritic cells to impair activation of antigen-specific CD4+ T cells","volume":"65","author":"Ohno","year":"2016","journal-title":"Cancer Immunol Immunother."},{"key":"B65","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2174\/1573395054065115","article-title":"Interleukin-12: an update on its immunological activities, signaling and regulation of gene expression","volume":"1","author":"Liu","year":"2005","journal-title":"Curr Immunol Rev."},{"key":"B66","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/icb.2012.9","article-title":"The interferons and their receptors\u2014distribution and regulation","volume":"90","author":"A","year":"2012","journal-title":"Immunol Cell Biol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.lfs.2014.07.021","article-title":"Attenuation of IFN-\u03b3-induced B7-H1 expression by 15-deoxy-delta12,14-prostaglandin J2 via downregulation of the Jak\/STAT\/IRF-1 signaling pathway","volume":"112","author":"Seo","year":"2014","journal-title":"Life Sci."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.celrep.2017.04.031","article-title":"Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression","volume":"19","author":"Garcia-Diaz","year":"2017","journal-title":"Cell Rep."},{"key":"B69","doi-asserted-by":"publisher","first-page":"e1008824","DOI":"10.1080\/2162402X.2015.1008824","article-title":"Interferon-\u03b3-induced activation of JAK1 and JAK2 suppresses tumor cell susceptibility to NK cells through upregulation of PD-L1 expression","volume":"4","author":"Bellucci","year":"2015","journal-title":"Oncoimmunology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1517\/14728222.10.3.459","article-title":"STAT3: a potential therapeutic target in dendritic cells for the induction of transplant tolerance","volume":"10","author":"Barton","year":"2006","journal-title":"Expert Opin Ther Targets"},{"key":"B71","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1212\/wnl.43.4.662","article-title":"Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial","volume":"43","author":"Paty","year":"1993","journal-title":"Neurology"},{"key":"B72","doi-asserted-by":"publisher","first-page":"4892","DOI":"10.1002\/cncr.27395","article-title":"Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults","volume":"118","author":"Martina","year":"2012","journal-title":"Cancer"},{"key":"B73","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat Rev Immunol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02129\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T08:16:36Z","timestamp":1693901796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02129\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,27]]},"references-count":73,"alternative-id":["10.3389\/fimmu.2018.02129"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02129","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2018.02129.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2018.02129.s002","asserted-by":"subject"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,27]]},"article-number":"2129"}}